UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

Clinical infectious diseases, 2018-08, Vol.67 (5), p.649-656

2018

Volltextzugriff (PDF)

Predicting the public health benefit of vaccinating cattle against Escherichia coli O157

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (40), p.16265-16270

2013

Volltextzugriff (PDF)

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials

Atherosclerosis, 2012-08, Vol.223 (2), p.251-261

2012

Volltextzugriff (PDF)

Utility of Whole-Genome Sequencing of Escherichia coli O157 for Outbreak Detection and Epidemiological Surveillance

Journal of clinical microbiology, 2015-11, Vol.53 (11), p.3565-3573

2015

Volltextzugriff (PDF)

Development of Pandemic Vaccines: ERVEBO Case Study

Vaccines (Basel), 2021-02, Vol.9 (3), p.190

2021

Volltextzugriff (PDF)

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Vaccine, 2022-11, Vol.40 (46), p.6599-6606

2022

Volltextzugriff (PDF)

Tree cover mapping based on Sentinel-2 images demonstrate high thematic accuracy in Europe

International journal of applied earth observation and geoinformation, 2020-02, Vol.84, p.101947-101947, Article 101947

2020

Volltextzugriff (PDF)

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection

Clinical infectious diseases, 2017-10, Vol.65 (7), p.1218-1221

2017

Volltextzugriff (PDF)

Costs associated with outpatient, emergency room and inpatient care for migraine in the USA

Cephalalgia, 2011-11, Vol.31 (15), p.1570-1575

2011

Volltextzugriff (PDF)

A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients

Frontiers in microbiology, 2016-06, Vol.7, p.915-915

2016

Volltextzugriff (PDF)

Analysis of C. difficile infection–related outcomes in European participants in the bezlotoxumab MODIFY I and II trials

European journal of clinical microbiology & infectious diseases, 2020-10, Vol.39 (10), p.1933-1939

2020

Volltextzugriff (PDF)

Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry

Clinical cardiology (Mahwah, N.J.), 2016-11, Vol.39 (11), p.670-677

2016

Volltextzugriff (PDF)

Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients

Atherosclerosis, 2015-06, Vol.240 (2), p.482-489

2015

Volltextzugriff (PDF)

One year prospective survey of Candida bloodstream infections in Scotland

Journal of medical microbiology, 2007-08, Vol.56 (8), p.1066-1075

2007

Volltextzugriff (PDF)

COVID-19 vaccination readiness among nurse faculty and student nurses

Nursing outlook, 2021-07, Vol.69 (4), p.565-573

2021

Volltextzugriff (PDF)

Interprofessional Graduate Students’ Perspectives on Caring for Vulnerable Populations

Nursing education perspectives, 2016-09, Vol.37 (5), p.281-282

2016

Volltextzugriff (PDF)

Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008

Emerging infectious diseases, 2011-03, Vol.17 (3), p.524-527

2011

Volltextzugriff (PDF)

Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)

The American journal of cardiology, 2010-03, Vol.105 (5), p.656-663

2010

Volltextzugriff (PDF)

Efficacy of Bezlotoxumab in Patients with Recurrent Clostridium Difficile Infection (CDI): Pooled Analysis of Data from the Modify Trials

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S343-S343

2017

Volltextzugriff (PDF)

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease

The American journal of cardiology, 2008-12, Vol.102 (11), p.1495-1501

2008

Volltextzugriff (PDF)

Attitudes and perceptions about cigarette smoking among nonsmoking high school students

Journal of the American Association of Nurse Practitioners, 2018-02, Vol.30 (2), p.60-63

Hanson, Mary Jane S

2018

Volltextzugriff (PDF)

Whole Genome Sequencing demonstrates that Geographic Variation of Escherichia coli O157 Genotypes Dominates Host Association

Scientific reports, 2015-10, Vol.5 (1), p.14145-14145, Article 14145

2015

Volltextzugriff (PDF)

Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry

Clinical cardiology (Mahwah, N.J.), 2017-09, Vol.40 (9), p.710-718

2017

Volltextzugriff (PDF)

Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection

PloS one, 2020-06, Vol.15 (6), p.e0235139

2020

Volltextzugriff (PDF)

A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma

International journal of hematology, 2016-01, Vol.103 (1), p.25-33

2016

Volltextzugriff (PDF)

1 – 25 von 985

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(854)
Mit Volltextzugriff
(795)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

Predicting the public health benefit of vaccinating cattle against Escherichia coli O157

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials

Utility of Whole-Genome Sequencing of Escherichia coli O157 for Outbreak Detection and Epidemiological Surveillance

Development of Pandemic Vaccines: ERVEBO Case Study

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Tree cover mapping based on Sentinel-2 images demonstrate high thematic accuracy in Europe

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection

Costs associated with outpatient, emergency room and inpatient care for migraine in the USA

A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients

Analysis of C. difficile infection–related outcomes in European participants in the bezlotoxumab MODIFY I and II trials

Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry

Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients

One year prospective survey of Candida bloodstream infections in Scotland

COVID-19 vaccination readiness among nurse faculty and student nurses

Interprofessional Graduate Students’ Perspectives on Caring for Vulnerable Populations

Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008

Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)

Efficacy of Bezlotoxumab in Patients with Recurrent Clostridium Difficile Infection (CDI): Pooled Analysis of Data from the Modify Trials

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease

Attitudes and perceptions about cigarette smoking among nonsmoking high school students

Whole Genome Sequencing demonstrates that Geographic Variation of Escherichia coli O157 Genotypes Dominates Host Association

Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry

Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection

A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma

Suchergebnisse filtern